
MARKET TRENDS
5 Mar 2026
AI trial simulations help drugmakers test study designs before enrolling patients, reducing risk and accelerating the path to new medicine...

PARTNERSHIPS
3 Mar 2026
Illumina completes its SomaLogic acquisition, expanding beyond DNA sequencing into integrated, end-to-end multi-omics drug discovery

RESEARCH
27 Feb 2026
Valinor and Renew join forces to build a vast AI-ready neurology dataset, hoping to sharpen drug discovery for Alzheimer’s, Parkinson’s, a...

MARKET TRENDS
19 Feb 2026
AI-powered multi-omics is reshaping drug discovery, but business models and market claims demand a closer look

RESEARCH
13 Feb 2026
Athos and Xeptiva use AI-powered multi-omics to sharpen drug discovery and reduce costly development risks

INNOVATION
11 Feb 2026
BioNeMo links AI models with lab testing, aiming to speed drug research and cut costs through closer industry collaboration
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.